Market Overview:
The global intrauterine contraceptive market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing awareness about contraception, rising prevalence of unintended pregnancies, and technological advancements in intrauterine contraceptive devices (IUDs). Based on type, the global intrauterine contraceptive market is segmented into nonhormonal IUDs and hormonal IUDs. Nonhormonal IUDs are further classified into copper-containing IUDs and other noncopper-containing IUDs. Hormonal IUDs are further classified into levonorgestrel-releasing (LNG) implants and etonogestrel-releasing (ENG) implants. Based on application, the global intrauterine contraceptive market is segmented into hospitals, community health care centers, and others. Geographically, the global intrauterine contraceptive market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . The North American region dominates the global Intrauterine Contraceptive Market due to high prevalence of unintended pregnancies coupled with increasing demand for long acting reversible contraceptives (LARC). In addition,.the presence of major players such as Bayer AG , Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Pfizer Inc.
Product Definition:
An intrauterine contraceptive is a T-shaped device made of plastic or metal that is inserted into the uterus to prevent pregnancy. Intrauterine contraceptives are very effective at preventing pregnancy and are also reversible.
Nonhormonal Intrauterine Contraceptive Devices:
Nonhormonal Intrauterine Contraceptive Devices (NIC) are a group of birth control methods that work by obstructing the sperm from fertilization. They can be used by women who are at risk of getting pregnant as well as those who do not want to become pregnant. NICs include intrauterine devices (IUD), subdermal implants, and vaginal rings among others.
Hormonal Intrauterine Contraceptive Devices:
Hormonal intrauterine contraceptive devices (IUDs) are a group of birth control methods that include Sino-implant (II), Para guard, and other nonhormonal IUDs. Hormonal IUDs work by stopping the release of fertile eggs from ovaries. They can be placed in the uterus for effective contraception.
Application Insights:
Based on application, the global intrauterine contraceptive market is segmented into hospitals, community health care centers and others. Hospitals held the largest share in 2017 owing to high usage of hormonal contraceptives among women hospitalized for childbirth. This is due to convenience and ease of use as well as because these devices are considered safer than those used by women at home.
The use of IUDs among nulligravid (non-pregnant) women has increased significantly over the past few years owing to their safety along with their ability to provide long-term contraception without any additional complications during pregnancy or after removal from uterus. In addition, growing awareness about these devices coupled with rising healthcare facilities in developing countries such as India is expected to fuel growth over the forecast period.
IUDs are also gaining popularity among other groups including adolescents.
Regional Analysis:
Asia Pacific dominated the global intrauterine contraceptive market in 2017. This is attributed to various factors such as rising awareness about contraceptives, increasing availability of IUDs and other devices, and rising demand for long-term contraception. According to WHO, approximately 60% of all IUDs distributed globally are from Asia. Moreover, a large number of women in this region use modern contraceptive methods (such as injectables and implants) despite cultural barriers or limited access to these methods due to financial constraints or because they do not consider them necessary at this time.
North America is expected to grow significantly over the forecast period owing to an increase in demand for highly effective contraceptives that do not involve any hormone therapy or surgery on the part of women seeking family planning services along with growing awareness about these products among young people aged 15-24 years old who make up a large proportion of those seeking family planning services each year. The U.S.
Growth Factors:
- Increasing awareness about contraception and intrauterine contraceptive devices (IUDs) among women of childbearing age
- Rising incidence of unintended pregnancies, especially in developing countries
- Growing demand for long-acting reversible contraceptives (LARCs) such as IUDs
- Improved access to quality healthcare services, including family planning counseling and services
- Increased affordability of IUDs due to increasing competition among manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrauterine Contraceptive Market Research Report
By Type
Nonhormonal Intrauterine Contraceptive Devices, Hormonal Intrauterine Contraceptive Devices
By Application
Hospitals, Community Health Care Centers, Others
By Companies
DKT International, Melbea AG, Pregna International Limited, Ocon Medical Ltd, SMB Corporation of India, Mona Lisa N.V.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Intrauterine Contraceptive Market Report Segments:
The global Intrauterine Contraceptive market is segmented on the basis of:
Types
Nonhormonal Intrauterine Contraceptive Devices, Hormonal Intrauterine Contraceptive Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Community Health Care Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DKT International
- Melbea AG
- Pregna International Limited
- Ocon Medical Ltd
- SMB Corporation of India
- Mona Lisa N.V.
Highlights of The Intrauterine Contraceptive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nonhormonal Intrauterine Contraceptive Devices
- Hormonal Intrauterine Contraceptive Devices
- By Application:
- Hospitals
- Community Health Care Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrauterine Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrauterine contraception (IUC) is a form of birth control that involves using a device to prevent pregnancy inside the uterus. IUC devices are inserted into the uterus by a doctor or other health care professional. They work by preventing sperm from reaching and fertilizing an egg.
Some of the major companies in the intrauterine contraceptive market are DKT International, Melbea AG, Pregna International Limited, Ocon Medical Ltd, SMB Corporation of India, Mona Lisa N.V..
The intrauterine contraceptive market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intrauterine Contraceptive Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intrauterine Contraceptive Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intrauterine Contraceptive Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intrauterine Contraceptive Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intrauterine Contraceptive Market Size & Forecast, 2020-2028
4.5.1 Intrauterine Contraceptive Market Size and Y-o-Y Growth
4.5.2 Intrauterine Contraceptive Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nonhormonal Intrauterine Contraceptive Devices
5.2.2 Hormonal Intrauterine Contraceptive Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Community Health Care Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intrauterine Contraceptive Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intrauterine Contraceptive Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nonhormonal Intrauterine Contraceptive Devices
9.6.2 Hormonal Intrauterine Contraceptive Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Community Health Care Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nonhormonal Intrauterine Contraceptive Devices
10.6.2 Hormonal Intrauterine Contraceptive Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Community Health Care Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nonhormonal Intrauterine Contraceptive Devices
11.6.2 Hormonal Intrauterine Contraceptive Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Community Health Care Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nonhormonal Intrauterine Contraceptive Devices
12.6.2 Hormonal Intrauterine Contraceptive Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Community Health Care Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nonhormonal Intrauterine Contraceptive Devices
13.6.2 Hormonal Intrauterine Contraceptive Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Community Health Care Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intrauterine Contraceptive Market: Competitive Dashboard
14.2 Global Intrauterine Contraceptive Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 DKT International
14.3.2 Melbea AG
14.3.3 Pregna International Limited
14.3.4 Ocon Medical Ltd
14.3.5 SMB Corporation of India
14.3.6 Mona Lisa N.V.
